XML 35 R25.htm IDEA: XBRL DOCUMENT v3.25.2
Equity (Tables)
6 Months Ended
Jun. 30, 2025
Summary of warrants outstanding

Warrants 

Pre-Funded Warrants(1) 

(in thousands, except per share data)

Number

Wtd. Avg. Exercise Price 

Wtd. Avg. Remaining Life (in years) 

Aggregate Intrinsic Value

Number

Wtd. Avg. Exercise Price

Aggregate Intrinsic Value

Beginning Balance 

21,295

$

1.0535

4.74

$

8,230

4,499

$

0.0001

$

6,478

Granted

Exercised 

(23)

1.0500

(1,703)

0.0001

Forfeited/Expired 

Outstanding at Period End 

21,272

$

1.0535

4.24

$

2,796

$

0.0001

$

1,565

(1) Pre-funded warrants have no expiration date and only expire when exercised in full. 

Schedule of outstanding, reserved and authorized shares under share-based compensation plans

June 30, 

December 31, 

(in thousands)

    

2025

    

2024

Outstanding options and restricted stock units

 

3,474

 

3,316

Reserved but unissued shares under the Plan

1,692

1,858

Reserved but unissued shares at end of period

 

5,166

 

5,174

Schedule of stock option activity

June 30, 

2025

(in thousands, except per share data)

Options to Purchase Common Stock

Weighted Average Exercise Price

Weighted Average Remaining Contractual Life (in years)

Aggregate Intrinsic Value

Outstanding at beginning of year

 

2,452

$

2.04

 

4.92

$

496

Granted

 

$

 

Exercised

 

$

 

Forfeited/Expired

 

(55)

$

2.56

 

Outstanding at end of period

 

2,397

$

2.03

 

4.18

$

Exercisable at end of period

 

1,872

$

1.70

 

3.78

$

Schedule of restricted stock unit activity

June 30, 

2025

(in thousands, except per share data)

Number of Shares

Weighted Average Grant Date Fair Value

Weighted Average Contractual Life (in years) (1)

Nonvested at beginning of year

 

865

$

0.99

0.88

Granted

 

393

$

0.91

Vested

 

(121)

$

0.91

Forfeited

(60)

$

0.92

Nonvested at end of period

 

1,077

$

0.97

1.36

Schedule of share-based compensation activity

June 30, 

(in thousands)

    

2025

    

Reserved but unissued shares at beginning of period

264

Increases in the number of authorized shares

21

Grants

(7)

Reserved but unissued shares at end of period

 

278

Restricted Stock Units  
Schedule of compensation expense

For the Three Months Ended

For the Six Months Ended

June 30, 

June 30, 

(in thousands, except per share data)

2025

2024

2025

    

2024

Share-based compensation expense

$

34

$

306

$

66

$

342

Weighted average value per share

$

0.89

$

1.36

$

0.89

$

1.32

Equity Incentive Plan  
Schedule of compensation expense

2025

2024

(in thousands, except per share data)

Number of Shares

    

Fair Value

Weighted Average per Share

Number of Shares

    

Fair Value

Weighted Average per Share

Fair value of stock payments in accrued compensation

326

$

279

$

0.85

307

$

326

$

1.06

Consultant Stock Plan  
Schedule of compensation expense

For the Three Months Ended

For the Six Months Ended

June 30, 

June 30, 

(in thousands, except per share data)

2025

    

2024

    

2025

    

2024

Share-based compensation expense

$

3

$

3

$

7

$

6

Weighted average value per share

$

0.94

$

0.81

$

0.94

$

0.81

Non-Qualified Stock Option  
Schedule of stock option activity

June 30, 

2025

(in thousands, except per share data)

Options to Purchase Common Stock

Weighted Average Exercise Price

Weighted Average Remaining Contractual Life (in years)

Aggregate Intrinsic Value

Outstanding at beginning of year

 

491

$

1.53

 

3.04

$

119

Granted

 

$

 

Exercised

 

$

 

Forfeited/Expired

 

$

 

Outstanding at end of period

 

491

$

1.53

 

2.55

$

Exercisable at end of period

 

441

$

1.60

 

2.79

$